Global Hepatitis C Treatment Market Trajectory & Analytics to 2027: Japan and Canada are Forecast to Grow at 8.4% and 10.1% Respectively over the 2020-2027 Period – ResearchAndMarkets.com

Global Hepatitis C Treatment Market Trajectory & Analytics to 2027: Japan and Canada are Forecast to Grow at 8.4% and 10.1% Respectively over the 2020-2027 Period – ResearchAndMarkets.com




Global Hepatitis C Treatment Market Trajectory & Analytics to 2027: Japan and Canada are Forecast to Grow at 8.4% and 10.1% Respectively over the 2020-2027 Period – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Hepatitis C Treatment – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Amid the COVID-19 crisis, the global market for Hepatitis C Treatment estimated at US$37.8 Billion in the year 2020, is projected to reach a revised size of US$82.3 Billion by 2027, growing at a CAGR of 11.7% over the analysis period 2020-2027.

HCV Protease Inhibitors, one of the segments analyzed in the report, is projected to record a 10.1% CAGR and reach US$9.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the HCV Polymerase Inhibitors segment is readjusted to a revised 11.3% CAGR for the next 7-year period.

The Hepatitis C Treatment market in the U.S. is estimated at US$10.2 Billion in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$17.6 Billion by the year 2027 trailing a CAGR of 15.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.4% and 10.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.2% CAGR.

In the global HCV NS5A Inhibitors segment, USA, Canada, Japan, China and Europe will drive the 11.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2 Billion in the year 2020 will reach a projected size of US$4.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$12.1 Billion by the year 2027, while Latin America will expand at a 13.3% CAGR through the analysis period.

Select Competitors (Total 123 Featured):

  • AbbVie, Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche AG
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Kadmon Holdings, Inc.
  • Merck & Co., Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 123

     

For more information about this report visit https://www.researchandmarkets.com/r/9lbcnc

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900